gfp,
re: CCXI
I looked at the briefing docs and I'm no expert in these things, but I don't see how the drug can be approved, regardless of panel decision. Maybe this is another Dendreon-type situation, but I wouldn't bet on it.
CCXI was once my largest position. I sold my last tranche at $64.50, so this was my largest gain on any stock ever. This stock secured my retirement. It was dumb luck.
Bladerunner